Skip to main content
. 2024 Nov 23;16(11):e74290. doi: 10.7759/cureus.74290

Figure 4. Distinctive findings suggest a malignancy.

Figure 4

A: The appearance of the grade 2 endometrial cancer after use of the GnRH antagonist under hysteroscopy. The lesion appeared as a flattened, map-like area lining the lower to the circumferential uterine cavity, composed of white, non-translucent tissue with villous-like thickness—an atypical appearance for endometrial polyps. B: Schermer depicts the spread of cancer.

GnRH: Gonadotropin-releasing hormone